Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.46 |
| ▸ | MGLL | Q99685 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 3/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | CDC25A | P30304 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5584067 | 1.00 | PTGS1 (0.46) | PTGS1PTGS2MGLLFAAHCNR1 | |
| SCHEMBL5584605 | 1.00 | PTGS1 (0.46) | PTGS1PTGS2MGLLFAAHCNR1 | |
| SCHEMBL20462217 | 0.90 | PTGS1 (0.38) | PTGS1PTGS2MGLLFAAHCNR1 | |
| SCHEMBL8282748 | 0.82 | SMN1; SMN2 (0.38) | NR1H2NR1H3 | |
| SCHEMBL11272468 | 0.82 | MGLL (0.47) | PTGS1PTGS2MGLLFAAHCNR1 | |
| SCHEMBL8282733 | 0.80 | SMN1; SMN2 (0.36) | NR1H2NR1H3 | |
| SCHEMBL16677017 | 0.80 | RAB9A (0.34) | NR1H2NR1H3 | |
| SCHEMBL16674714 | 0.78 | MEN1 (0.44) | — | |
| SCHEMBL5586971 | 0.77 | ELANE (0.44) | MGLL | |
| SCHEMBL7968322 | 0.76 | PLA2G7 (0.47) | PTGS1PTGS2MGLLFAAHCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190055414-A1 | N-HALAMINES COMPOUNDS AS MULTIFUNCTIONAL ADDITIVES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2019-02-21 | — | — | US | claimed |
| US-10138379-B2 | N-halamines compounds as multifunctional additives | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-11-27 | — | — | US | claimed |
| US-20150166796-A1 | N-Halamines Compounds as Multifunctional Additives | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2015-06-18 | — | — | US | claimed |
| US-20070062884-A1 | N-halamines compounds as multifunctional additives | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166796-A1 | N-Halamines Compounds as Multifunctional Additives | NIT2, AAAS, NACA | PTGS1 3492/4885PTGS2 3713/4885MGLL 998/4885 |
| US-10138379-B2 | N-halamines compounds as multifunctional additives | NIT2, AAAS, NACA | PTGS1 3492/4885PTGS2 3713/4885MGLL 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.